Bill Brooks, vice president of transportation with Capgemini North America, Inc., lays out the multiple challenges involved in manufacturing, storing and delivering millions of doses of the vaccine for COVID-19 in the coming months.

Bill DeMartino, managing director for the Americas with Riskmethods, discusses how the coronavirus pandemic is impacting risk-management strategies, and whether companies were ready for the disruption that it has caused.

Meal-kit delivery services, already on a steady growth curve prior to this year, have seen sales explode with the coming of COVID-19. Now they’re scurrying to keep pace with demand — and hang on to their customers.

Daniel Hartnett, associate managing director of the Compliance Risk & Diligence Practice of Kroll, advises on the steps that pharmaceutical companies should take to reduce the risk of dealing with third parties, as they develop a COVID-19 vaccine.